Lenvatinib Therapy in Patients with Unresectable Hepatocellular Carcinoma in Real Clinical Practice

Lenvatinib Therapy in Patients with Unresectable Hepatocellular Carcinoma in Real Clinical Practice

Aim. To determine lenvatinib treatment outcomes in patients with advanced unresectable hepatocellular carcinoma (uHCC) in real clinical practice.Patients and methods. A multicenter retrospective observational study included 58 patients with a confirmed uHCC diagnosis receiving lenvatinib. At baselin...

Full description

Bibliographic Details
Main Authors: V. V. Petkau, A. V. Sultanbaev, K. V. Menshikov, A. S. Antipin, M. V. Volkonsky, V. M. Filippova, Yu. V. Vasilyeva, A. A. Tarkhanov, M. R. Mukhitova, M. Zh. Murzalina, A. R. Safarova
Format: Article
Language:Russian
Published: Gastro LLC 2022-12-01
Series:Российский журнал гастроэнтерологии, гепатологии, колопроктологии
Subjects:
liver cancer
hepatocellular carcinoma
hcc
targeted therapy
lenvatinib
real clinical practice
Online Access:https://www.gastro-j.ru/jour/article/view/723

Internet

https://www.gastro-j.ru/jour/article/view/723

Similar Items